{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:13Z","timestamp":1786995673663,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pharma.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:19:33Z","timestamp":1769098773000},"page":"662-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E\u2013infected mouse model"],"prefix":"10.1016","volume":"84","author":[{"given":"Shrikant S.","family":"Magdum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Disouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arehalli S.","family":"Manjappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil T.","family":"Galatage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.pharma.2026.01.004_bib0490","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pharma.2026.01.004_bib0495","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"Long-term effects of COVID-19: a systematic review and meta-analysis","volume":"11","author":"Lopez-Leon","year":"2021","journal-title":"Sci Rep"},{"issue":"10317","key":"10.1016\/j.pharma.2026.01.004_bib0500","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.004_bib0505","doi-asserted-by":"crossref","first-page":"100407","DOI":"10.1016\/j.imr.2020.100407","article-title":"Herbal medicine as an adjunct treatment for COVID-19: a systematic review","volume":"9","author":"Ang","year":"2020","journal-title":"Integr Med Res"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.004_bib0510","first-page":"1","article-title":"Herbal medicines and phytochemicals for COVID-19 management","volume":"39","author":"Khanna","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.pharma.2026.01.004_bib0515","first-page":"110492","article-title":"Natural product-derived antivirals against coronaviruses","volume":"129","author":"Mani","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.004_bib0520","first-page":"4111","article-title":"In silico screening of phytochemicals for SARS-CoV-2 inhibition","volume":"39","author":"Gupta","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.004_bib0525","first-page":"4149","article-title":"Computational evaluation of phytochemicals targeting SARS-CoV-2","volume":"39","author":"Ibrahim","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.pharma.2026.01.004_bib0530","doi-asserted-by":"crossref","first-page":"906531","DOI":"10.3389\/fphar.2022.906764","article-title":"Herbal medicine for COVID-19: overview of systematic reviews","volume":"13","author":"Ang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0535","first-page":"112956","article-title":"Anti-inflammatory and immunomodulatory effects of Clerodendrum serratum","volume":"259","author":"Singh","year":"2020","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.004_bib0540","first-page":"4747","article-title":"Piperine as a broad-spectrum antiviral","volume":"35","author":"Gautam","year":"2021","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.004_bib0545","first-page":"144","article-title":"Clinical significance of Tinospora cordifolia in COVID-19 patients","volume":"42","author":"Rathi","year":"2021","journal-title":"Ayu"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.004_bib0550","first-page":"4412","article-title":"Antiviral effects of Zingiber officinale","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2026.01.004_bib0555","first-page":"675480","article-title":"Therapeutic potential of Phyllanthus emblica","volume":"12","author":"Ghosh","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0560","first-page":"45","article-title":"Chebulagic acid inhibits viral entry","volume":"167","author":"Choi","year":"2019","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0565","first-page":"457","article-title":"Antiviral activities of Swertia chirayita","volume":"56","author":"Sharma","year":"2018","journal-title":"Pharm Biol"},{"issue":"18","key":"10.1016\/j.pharma.2026.01.004_bib0570","first-page":"6732","article-title":"Plumbagin inhibits SARS-CoV-2 Mpro","volume":"39","author":"Kumar","year":"2021","journal-title":"J Biomol Struct Dyn"},{"issue":"4617","key":"10.1016\/j.pharma.2026.01.004_bib0575","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1811199a0","article-title":"Antioxidant determination using stable free radical","volume":"181","author":"Blois","year":"1958","journal-title":"Nature"},{"issue":"9\u201310","key":"10.1016\/j.pharma.2026.01.004_bib0580","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"ABTS radical cation assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2026.01.004_bib0585","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cell viability","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0590","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00011-007-6115-5","article-title":"THP-1 differentiation optimization","volume":"56","author":"Park","year":"2007","journal-title":"Inflamm Res"},{"issue":"5\u20136","key":"10.1016\/j.pharma.2026.01.004_bib0595","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0891-5849(99)00107-0","article-title":"DCFH-DA oxidative stress assay","volume":"27","author":"Wang","year":"1999","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.004_bib0600","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Antimicrobial activity evaluation methods","volume":"6","author":"Balouiri","year":"2016","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.pharma.2026.01.004_bib0605","doi-asserted-by":"crossref","first-page":"100197","DOI":"10.1016\/j.microb.2024.100197","article-title":"Green synthesis of AgNPs from Clematis gouriana","volume":"5","author":"Yadav","year":"2024","journal-title":"Microbe"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.004_bib0610","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.pharma.2022.12.007","article-title":"Emilia sonchifolia-mediated AgNPs","volume":"81","author":"Galatage","year":"2023","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.pharma.2026.01.004_bib0615","doi-asserted-by":"crossref","first-page":"106469","DOI":"10.1016\/j.jddst.2024.106469","article-title":"Palbociclib-letrozole SNEDDS","volume":"104","author":"Galatage","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.004_bib0620","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"Fifty percent endpoint estimation","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.004_bib0625","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3201\/eid2606.200516","article-title":"Isolation of SARS-CoV-2 in USA","volume":"26","author":"Harcourt","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.004_bib0630","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5439","article-title":"RNA purification using TRIzol","volume":"2010","author":"Rio","year":"2010","journal-title":"Cold Spring Harb Protoc"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.004_bib0635","first-page":"195","article-title":"RT-LAMP detection of coronavirus","volume":"189","author":"Shirato","year":"2014","journal-title":"J Virol Methods"},{"key":"10.1016\/j.pharma.2026.01.004_bib0640","first-page":"104855","article-title":"Heparin inhibits SARS-CoV-2 invasion","volume":"181","author":"Zhang","year":"2020","journal-title":"Antiviral Res"},{"issue":"14","key":"10.1016\/j.pharma.2026.01.004_bib0645","first-page":"915","article-title":"Self-emulsifying celecoxib formulation","volume":"46","author":"Okafor","year":"2025","journal-title":"J Dispersion Sci Technol"},{"issue":"11","key":"10.1016\/j.pharma.2026.01.004_bib0650","first-page":"742","article-title":"Atorvastatin SNEDDS pharmacokinetics","volume":"46","author":"Huang","year":"2025","journal-title":"J Dispersion Sci Technol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0655","doi-asserted-by":"crossref","first-page":"103929","DOI":"10.1016\/j.jddst.2022.103929","article-title":"Camptothecin SNEDDS","volume":"78","author":"Galatage","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0660","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejpb.2023.10.013","article-title":"Fosfestrol SNEDDS","volume":"193","author":"Galatage","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0665","first-page":"112","article-title":"Lipid-based anticancer nanoformulations","volume":"14","author":"Patel","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.pharma.2026.01.004_bib0670","first-page":"123092","article-title":"SNEDDS for oral lipophilic drugs","volume":"642","author":"Chen","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2026.01.004_bib0675","first-page":"122497","article-title":"Lipid formulations for TKIs","volume":"632","author":"Chen","year":"2023","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.pharma.2026.01.004_bib0680","first-page":"149","article-title":"Blood and tissue collection in rodents","volume":"49","author":"Carvalho","year":"2020","journal-title":"Lab Anim (NY)"},{"issue":"5","key":"10.1016\/j.pharma.2026.01.004_bib0685","first-page":"292","article-title":"TRIzol RNA isolation update","volume":"68","author":"Zhou","year":"2020","journal-title":"Biotechniques"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.004_bib0690","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"Mathematical model for RT-PCR quantification","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.004_bib0695","first-page":"1463","article-title":"T-cell receptor repertoire","volume":"128","author":"De Rosa","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharma.2026.01.004_bib0700","first-page":"1","article-title":"Flow cytometric immune analysis","volume":"468","author":"Lee","year":"2019","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.pharma.2026.01.004_bib0705","first-page":"112743","article-title":"Cytokine ELISA quantification","volume":"478","author":"Zhang","year":"2020","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.004_bib0710","first-page":"89","article-title":"Histopathological analysis in animals","volume":"36","author":"Wang","year":"2021","journal-title":"J Tissue Pathol"},{"issue":"5","key":"10.1016\/j.pharma.2026.01.004_bib0715","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/oxim.2.5.9498","article-title":"Plant polyphenols as antioxidants","volume":"2","author":"Pandey","year":"2009","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0720","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1039\/c0fo00103a","article-title":"Anti-inflammatory flavonoids","volume":"1","author":"Pan","year":"2010","journal-title":"Food Funct"},{"key":"10.1016\/j.pharma.2026.01.004_bib0725","doi-asserted-by":"crossref","first-page":"100407","DOI":"10.1016\/j.hermed.2020.100407","article-title":"Cytotoxic activity of medicinal plants","volume":"25","author":"Sharma","year":"2021","journal-title":"J Herb Med"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.004_bib0730","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signalling","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.004_bib0735","first-page":"1343","article-title":"Flavonoids as anticancer agents","volume":"43","author":"Zhao","year":"2023","journal-title":"Med Res Rev"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0740","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","article-title":"Quercetin in disease prevention","volume":"83","author":"Russo","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"10.1016\/j.pharma.2026.01.004_bib0745","first-page":"4102","article-title":"Citrus flavonoids anti-inflammatory effects","volume":"60","author":"Huang","year":"2012","journal-title":"J Agric Food Chem"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.004_bib0750","first-page":"932","article-title":"Scopoletin suppresses PGE2 production","volume":"10","author":"Choi","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.004_bib0755","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections in COVID-19","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0760","first-page":"166","article-title":"Invasive fungal disease in COVID-19","volume":"75","author":"Hoenigl","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.004_bib0765","first-page":"e10726","article-title":"Rhino-orbital mucormycosis in COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.pharma.2026.01.004_bib0770","first-page":"113541","article-title":"Tinospora cordifolia immunomodulators","volume":"267","author":"Sharma","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0775","first-page":"126836","article-title":"Antioxidant activity of ginger","volume":"326","author":"Zeng","year":"2020","journal-title":"Food Chem"},{"issue":"2\u20133","key":"10.1016\/j.pharma.2026.01.004_bib0780","first-page":"197","article-title":"Antioxidant potential of Phyllanthus emblica","volume":"82","author":"Saleem","year":"2002","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0785","first-page":"7","article-title":"Antioxidant activity of Triphala","volume":"81","author":"Sabu","year":"2002","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.004_bib0790","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/10408390601062054","article-title":"Black pepper bioactive compounds","volume":"47","author":"Srinivasan","year":"2007","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"5","key":"10.1016\/j.pharma.2026.01.004_bib0795","first-page":"417","article-title":"Swertia chirayita: recent advances","volume":"11","author":"Joshi","year":"2021","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.pharma.2026.01.004_bib0800","first-page":"153579","article-title":"Plumbagin modulates NF-\u03baB and Nrf2","volume":"87","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.004_bib0805","first-page":"1036","article-title":"Antifungal mechanisms of plumbagin","volume":"8","author":"Singh","year":"2022","journal-title":"J Fungi"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0810","first-page":"142","article-title":"Antifungal activity of Terminalia spp","volume":"55","author":"Sharma","year":"2017","journal-title":"Pharm Biol"},{"issue":"3","key":"10.1016\/j.pharma.2026.01.004_bib0815","first-page":"169","article-title":"Antifungal efficacy of piperine","volume":"25","author":"Gupta","year":"2015","journal-title":"J Mycol Med"},{"issue":"8","key":"10.1016\/j.pharma.2026.01.004_bib0820","first-page":"1482","article-title":"Antifungal activity of ginger compounds","volume":"18","author":"Park","year":"2008","journal-title":"J Microbiol Biotechnol"},{"issue":"5\u20136","key":"10.1016\/j.pharma.2026.01.004_bib0825","first-page":"369","article-title":"Mangiferin inhibits Rhizopus","volume":"173","author":"Ahmad","year":"2012","journal-title":"Mycopathologia"},{"issue":"9","key":"10.1016\/j.pharma.2026.01.004_bib0830","first-page":"1764","article-title":"Molecular mechanisms of Phyllanthus emblica","volume":"11","author":"Reddy","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharma.2026.01.004_bib0835","first-page":"105075","article-title":"Antiviral phenolic compounds","volume":"190","author":"Yang","year":"2021","journal-title":"Antiviral Res"},{"key":"10.1016\/j.pharma.2026.01.004_bib0840","first-page":"628970","article-title":"Tinospora cordifolia antiviral activity","volume":"12","author":"Shanker","year":"2021","journal-title":"Front Pharmacol"},{"issue":"16","key":"10.1016\/j.pharma.2026.01.004_bib0845","first-page":"5887","article-title":"Polyphenols inhibit coronavirus proteases","volume":"48","author":"Chen","year":"2005","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0850","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jep.2012.10.043","article-title":"Antiviral activity of ginger","volume":"145","author":"Chang","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"10.1016\/j.pharma.2026.01.004_bib0855","first-page":"1936","article-title":"Mangiferin antiviral effects","volume":"30","author":"Hossain","year":"2016","journal-title":"Phytother Res"},{"key":"10.1016\/j.pharma.2026.01.004_bib0860","first-page":"119","article-title":"Plumbagin as antiviral agent","volume":"46","author":"Ahmad","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharma.2026.01.004_bib0865","doi-asserted-by":"crossref","first-page":"197989","DOI":"10.1016\/j.virusres.2020.197989","article-title":"Phytochemicals against coronaviruses","volume":"284","author":"Mani","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.pharma.2026.01.004_bib0870","first-page":"1","article-title":"Phytochemicals as antiviral agents","volume":"18","author":"Ghildiyal","year":"2020","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.pharma.2026.01.004_bib0875","first-page":"154934","article-title":"Polyherbal formulations against SARS-CoV-2","volume":"118","author":"Sarkar","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharma.2026.01.004_bib0880","first-page":"113122","article-title":"Plant-based antivirals for COVID-19","volume":"151","author":"Kumar","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharma.2026.01.004_bib0885","first-page":"116064","article-title":"Polyherbal synergy against COVID-19","volume":"304","author":"Singh","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0890","first-page":"131090","article-title":"Herbal bioactives targeting SARS-CoV-2","volume":"1245","author":"Rathinavel","year":"2021","journal-title":"J Mol Struct"},{"key":"10.1016\/j.pharma.2026.01.004_bib0895","first-page":"105574","article-title":"Phytochemicals in COVID-19 management","volume":"168","author":"Gautam","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.pharma.2026.01.004_bib0900","first-page":"112963","article-title":"Herbal SNEDDS for antiviral efficacy","volume":"220","author":"Nanjwade","year":"2023","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.pharma.2026.01.004_bib0905","first-page":"119532","article-title":"SNEDDS for antiviral phytochemicals","volume":"360","author":"Alam","year":"2022","journal-title":"J Mol Liq"},{"key":"10.1016\/j.pharma.2026.01.004_bib0910","first-page":"123092","article-title":"Nanoemulsion delivery of herbal antivirals","volume":"651","author":"Mohanraj","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2026.01.004_bib0915","first-page":"23","article-title":"Nanotechnology-enabled antiviral delivery","volume":"15","author":"Barani","year":"2022","journal-title":"Interdiscip Nanomed"},{"key":"10.1016\/j.pharma.2026.01.004_bib0920","first-page":"122140","article-title":"Polyherbal nanoformulations in COVID-19","volume":"332","author":"Sharma","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.pharma.2026.01.004_bib0925","doi-asserted-by":"crossref","first-page":"138277","DOI":"10.1016\/j.scitotenv.2020.138277","article-title":"COVID-19: a promising cure for the global panic","volume":"725","author":"Vellingiri","year":"2020","journal-title":"Sci Total Environ"},{"issue":"2","key":"10.1016\/j.pharma.2026.01.004_bib0930","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ptr.6873","article-title":"Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies","volume":"35","author":"Boozari","year":"2021","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.004_bib0935","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jtcme.2020.05.004","article-title":"Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective","volume":"10","author":"Panyod","year":"2020","journal-title":"J Tradit Complement Med"},{"issue":"10","key":"10.1016\/j.pharma.2026.01.004_bib0940","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.7150\/ijbs.45538","article-title":"Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.pharma.2026.01.004_bib0945","doi-asserted-by":"crossref","first-page":"581840","DOI":"10.3389\/fphar.2020.581840","article-title":"COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy?","volume":"11","author":"Silveira","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2026.01.004_bib0950","doi-asserted-by":"crossref","first-page":"198169","DOI":"10.1016\/j.virusres.2020.198169","article-title":"Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection","volume":"290","author":"Khare","year":"2021","journal-title":"Virus Res"},{"issue":"SI\u20131","key":"10.1016\/j.pharma.2026.01.004_bib0955","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3906\/biy-2005-114","article-title":"Potentials of plant-based substances to inhabit and probable cure for the COVID-19","volume":"44","author":"Jahan","year":"2020","journal-title":"Turk J Biol"},{"issue":"1","key":"10.1016\/j.pharma.2026.01.004_bib0960","first-page":"364","article-title":"Self-nanoemulsifying drug delivery systems (SNEDDS) for bioavailability enhancement of phytochemicals: a review","volume":"28","author":"Kotta","year":"2021","journal-title":"Drug Deliv"},{"issue":"4","key":"10.1016\/j.pharma.2026.01.004_bib0965","first-page":"495","article-title":"An alternative approach to minimize the risk of coronavirus (COVID-19) using phytochemicals and natural products","volume":"14","author":"Ahmad","year":"2021","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.pharma.2026.01.004_bib0970","first-page":"153541","article-title":"Identification of polyphenols from medicinal plants as potential inhibitors of SARS-CoV-2 main protease (Mpro): an in silico study","volume":"85","author":"Ghosh","year":"2021","journal-title":"Phytomedicine"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:21:01Z","timestamp":1781220061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450926000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0003450926000040"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.01.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of a polyherbal extract against COVID-19 and associated inflammation and mucormycosis: In vitro characterization and in vivo validation in a human coronavirus 229E\u2013infected mouse model","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}